Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04919538 · ClinicalTrials.gov registry record
Longitudinal Study for Relapsing Polychondritis
A clinical trial of Vasculitis and Relapsing Polychondritis, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT04919538: Recruiting study of Vasculitis and Relapsing Polychondritis, sponsored by University of Pennsylvania.
NCT04919538 is a study of Vasculitis and Relapsing Polychondritis that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 100 participants, below the 27,310-participant average among 11 other Vasculitis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04919538, a study of Vasculitis and Relapsing Polychondritis, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Relapsing polychondritis (RP) is a rare systemic inflammatory disease characterized by recurrent inflammation of cartilage including ears, nose, tracheobronchial tree, chest wall and joints. Less commonly, it can cause inflammation of eyes, vasculature, nervous system, skin and inner ear. The purpose of this study is to study the pathogenesis of RP.
Primary Outcome
To study the manner of development of disease in patients affected with relapsing polychondritis.
Conditions Studied
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-02-26 |
| Est. Completion | 2030-01 |
What NCT04919538 shows while recruiting
NCT04919538 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 27,310-participant average among 11 other Vasculitis trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Vasculitis appearing as the primary indexed condition, and to 0 interventions.
NCT04919538 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04919538 about?
NCT04919538 is a clinical study titled "Longitudinal Study for Relapsing Polychondritis". Relapsing polychondritis (RP) is a rare systemic inflammatory disease characterized by recurrent inflammation of cartilage including ears, nose, tracheobronchial tree, chest wall and joints. Less commonly, it can cause inflammation of eyes, vasculature, nervous system, skin and inner ear. The purpos...
What is the current status of trial NCT04919538?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2021-02-26. Estimated completion is 2030-01.
What conditions does trial NCT04919538 study?
This clinical trial studies the following conditions: Vasculitis, Relapsing Polychondritis.
Who is sponsoring clinical trial NCT04919538?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04919538 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vasculitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04919538's enrollment target sits among peer trials
100 2nd of 11 higher than 9 of 11 other Vasculitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vasculitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
RECRUITING · Phase 1
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
RECRUITING
-
Vasculitis Pregnancy Registry
RECRUITING
-
Longitudinal Study for Central Nervous System Vasculitis
RECRUITING
-
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI